Oligodendrocyte development is regulated by the interaction of repressors and activators in a complex transcriptional network. We found that two histone-modifying enzymes, HDAC1 and HDAC2, were required for oligodendrocyte formation. Genetic deletion of both Hdac1 and Hdac2 in oligodendrocyte lineage cells resulted in stabilization and nuclear translocation of b-catenin, which negatively regulates oligodendrocyte development by repressing Olig2 expression. We further identified the oligodendrocyterestricted transcription factor TCF7L2/TCF4 as a bipartite co-effector of b-catenin for regulating oligodendrocyte differentiation. Targeted disruption of Tcf7l2 in mice led to severe defects in oligodendrocyte maturation, whereas expression of its dominantrepressive form promoted precocious oligodendrocyte specification in developing chick neural tube. Transcriptional co-repressors HDAC1 and HDAC2 compete with b-catenin for TCF7L2 interaction to regulate downstream genes involved in oligodendrocyte differentiation. Thus, crosstalk between HDAC1/2 and the canonical Wnt signaling pathway mediated by TCF7L2 serves as a regulatory mechanism for oligodendrocyte differentiation.
Epigenetic chromatin remodeling events such as histone modification are essential for many biological processes, including neural cell fate specification and differentiation 1 . The histone deacetylases (HDACs) oppose the action of histone acetyltransferases, removing acetyl groups from histone lysine tails, which results in chromatin compaction. There are four classes of HDACs, which comprise a highly conserved enzyme family 2 . HDACs can be recruited to multiprotein transcriptional complexes on the genome and serve as epigenetic co-repressors to facilitate inhibition of target gene transcription.
HDAC activity is shown to be required for oligodendrocyte maturation 3, 4 . Using HDAC inhibitors, valproic acid and trichostatin A, oligodendrocyte differentiation is repressed in tissue culture studies and during animal development 3, 4 . Because these HDAC inhibitors have substantial affinities for multiple HDAC proteins, it is not clear which HDAC proteins are required for oligodendrocyte differentiation in vivo or how HDACs function in this process. Although morpholino-based knockdown of hdac1 in zebrafish leads to a loss of Olig2 (ref. 5) , an essential transcriptional regulator for oligodendrocyte development [6] [7] [8] , it is not clear that the effect of knockdown is a result of a cell-autonomous or nonautonomous function of HDAC1. In addition, the molecular mechanisms underlying the role of HDAC proteins in oligodendrocyte differentiation are not fully understood.
Wnt signaling is important in embryonic patterning, tissue homeostasis and cell fate determination 9, 10 . In the absence of Wnt signals, b-catenin is phosphorylated at several N-terminal residues and is subjected to ubiquitination and proteasome-mediated degradation. Wnt signaling activation inhibits the kinase activity of a destruction complex and therefore stabilizes b-catenin in the cytoplasm, which then translocates and accumulates in the nucleus. Nuclear b-catenin forms a bipartite transcriptional complex with a member of the TCF (T cell factor)/LEF (lymphoid enhancer family) transcription factor family. In the canonical Wnt/b-catenin pathway, the TCF factor (LEF1, TCF7/TCF1, TCF7L1/TCF3 or TCF7L2/ TCF4) transduces Wnt/b-catenin signals to activate downstream target genes 9 . This process requires the recruitment of multiple chromatin remodeling components, including HDACs 11, 12 . The Wnt signaling pathway appears to negatively regulate oligodendrocyte differentiation in vitro 13 . Notably, Wnt signaling is constitutively activated in the retina of zebrafish hdac1 homolog (adh1) mutants, suggesting that HDAC function may antagonize Wnt signaling 14 .
We examined the function of HDAC1 and HDAC2 in oligodendrocyte development. HDAC1 and HDAC2 proteins share 85% identity and have redundant functions during embryogenesis 15 . We generated mice with mutations in both Hdac1 and Hdac2 specifically in the oligodendrocyte lineage and found a critical redundant role for HDAC1/2 in oligodendrocyte differentiation. Activation of the canonical Wnt/b-catenin pathway contributed to the inhibition of oligodendrocyte differentiation in Hdac1/2 double mutant mice. We further identified the Wnt/b-catenin effector TCF7L2 as being an oligodendrocyte lineage-specific transcription factor and found that TCF7L2 was essential for oligodendrocyte differentiation. In addition, we found that binding between b-catenin and HDAC proteins switched TCF7L2 from a repressor to an activator of oligodendrocyte differentiation. Collectively, our findings indicate that HDAC1/2 regulate oligodendrocyte differentiation, at least in part, by inhibiting Wnt signaling through disrupting b-catenin-TCF interactions.
RESULTS

HDAC1/2 are required for oligodendrocyte differentiation
To assess the role of class I HDACs in oligodendrocyte development, we selectively deleted Hdac1 and Hdac2 in the oligodendrocyte lineage by mating Hdac1 loxP/loxP ; Hdac2 loxP/loxP mice with Olig1-cre mice 16 . When we crossed Olig1-cre mice with a ROSA26-lacZ reporter strain 17 , LacZ expression was initially detected in the motor neuron precursor domain for oligodendrocytes and motoneurons at embryonic day 12.5 (E12.5) and persisted in oligodendrocytes at postnatal stages ( Supplementary Fig. 1 online) . Consistent with these findings, ROSA26-yfp reporter mice 18 19 , and died around postnatal week 2. In dCKO mice at E12.5, Olig2 expression was maintained in the ventral ventricular zone of the spinal cord ( Fig. 1a,b ). At E16.5, we could not detect the expression of OPC markers Pdgfra and Olig2 and the mature oligodendrocyte markers myelin basic protein (Mbp) and Plp1 (also known as DM20) in dCKO mice ( Fig. 1c,d ). Even at postnatal day 4 (P4), these markers were not observed in dCKO mice ( Fig. 1) . In contrast, mice with a single deletion of Hdac1 or Hdac2 showed normal expression patterns of OPC and mature oligodendrocyte markers ( Fig. 1f,g) . These mice were also phenotypically identical to wild-type mice (data not shown). The deficit of OPCs was further confirmed by the expression of another OPC marker NG2 (ref. 20) . The NG2-positive OPCs were essentially diminished in dCKO mutant spinal cords at E18.5 ( Fig. 1j ) compared with controls ( Fig. 1i) . Similar to the finding in spinal cord, we observed a complete absence of mature oligodendrocytes and their progenitors in the postnatal brain of dCKO mice ( Supplementary Fig. 2 online) . This failure of OPC formation persisted into postnatal stages of dCKO mice, suggesting that HDAC1/2 are required for oligodendrocyte specification and differentiation.
Oligodendrocyte progenitor cultures from wild-type, Hdac1 loxP/loxP ; Olig1-cre (Hdac1 CKO) and Hdac2 loxP/loxP ; Olig1-cre (Hdac2 CKO) embryonic cortices expressed the oligodendrocyte differentiation marker RIP 3 d In situ hybridizations of cross-sections of spinal cord from wild-type (WT, a,c,e), Hdac1 loxP/loxP ; Olig1-cre (Hdac1 CKO, f), Hdac2 loxP/loxP ; Olig1-cre (Hdac2 CKO, g) and Hdac1 loxP/loxP ; Hdac2 loxP/loxP ; Olig1-cre (dCKO, b,d,h) mice at ages E12.5, E16.5 or P4, as indicated using probes for oligodendrocyte lineage markers Olig2, Pdgfra, Plp1 and Mbp. (i,j) Spinal cords from WT and dCKO mice at e18.5 were subject to double immunostaining with antibodies to NG2 (green) and PECAM1 (red). The PECAM1 antibody was used to distinguish OPCs from pericytes, as NG2 labels both OPCs and pericytes in the spinal cord. Arrows indicate in situ labeled cells (a-h) and NG2-or PECAM1-positive cells (i,j), respectively. Scale bars represent 100 mm.
after plating in oligodendrocyte differentiation medium ( Fig. 2a,b and data not shown). However, we did not detect RIP expression in cells isolated from dCKO mutant embryos ( Fig. 2c,d) . In contrast with the lack of OPC marker expression in the spinal cords of dCKO mice ( Fig. 1) , we observed Olig2-and Pdgfra-positive OPCs under the in vitro condition and they were maintained at the precursor stage without differentiation ( Fig. 2c,e ). These findings indicate that, although OPCs can be formed from dCKO mutant embryos under certain cell culture conditions, these cells do not mature into differentiated oligodendrocytes.
Motor neuron and astrocyte formation in HDAC1/2 mutants Motor neurons, which were derived from the Olig1-cre progenitor domain in the spinal cord, were examined in wild-type and dCKO embryos using the motor neuron markers Hb9 and Isl2 (ref. 21 ). We did not detect any defects in the formation of somatic motor neurons in the developing dCKO spinal cord ( Fig. 2) .
To determine whether astrocyte development is perturbed in dCKO mice, we examined the expression of glial fibrillary acid protein (GFAP), an astrocyte marker. Similar levels of GFAP were observed in the spinal cord of both wild-type and dCKO mice at E16.5 and E18.5 ( Fig. 2h ,i,k). We did not observe substantial apoptosis, as assessed by caspase-3 immunostaining and TUNEL staining, or alteration of cell proliferation and neurogenesis in the dCKO spinal cord (Supplementary Fig. 3 online and data not shown). In addition, we did not detect any defect in Schwann cell formation at any of the stages that we examined in the Olig1-cre-mediated dCKO mice (data not shown). Collectively, our data indicate that Olig1-cre-mediated oligodendrocytespecific ablation of Hdac1/2 selectively disrupts oligodendrocyte differentiation but does not perturb neuron or astrocyte development.
Stabilization of b-catenin in the absence of HDAC1/2 In zebrafish retina, HDAC1 was found to negatively regulate Wnt and Notch signaling 12 , which has been shown to inhibit oligodendrocyte differentiation 13 . Cortical progenitor cells isolated from dCKO embryos did not show an increase of expression of the Notch effectors Hes1 and Hes5 (data not shown). To examine whether inhibition of HDAC activity affects Wnt signal transduction, we transfected hippocampus-derived adult neural progenitor cells (HCN) 22 with a b-catenin/TCF luciferase reporter, TOPFLASH, carrying a b-catenin-responsive promoter 23 . This reporter responded to treatment with LiCl, an activator of Wnt signaling ( Fig. 3a) . Cells treated with the HDAC inhibitors trichostatin A and valproic acid showed enhanced TOPFLASH reporter activity over the negative control FOPFLASH reporter ( Fig. 3a) . These data suggest that inhibition of HDAC activity enhances canonical Wnt signal transduction.
To further assess in vivo Wnt/b-catenin activation in dCKO mice, we bred a BAT-gal reporter line with Hdac1 loxP/loxP ; Hdac2 loxP/loxP mice to generate dCKO mice carrying the BAT-gal reporter. In the BAT-gal transgenic line, a b-galactosidase reporter is expressed under the control of multiple b-catenin/T cell factor responsive elements 24 (Fig. 3b ). Compared with control mice at E13.5 ( Fig. 3c,d) , in which b-galactosidase activity is mainly detected in the dorsal spinal cord, which shows a high Wnt/b-catenin activity, Hdac1/2 deletion resulted in wide-spread b-galactosidase reporter expression in unidentified cells throughout the cord (Fig. 3e) . These observations suggest that Hdac1/2 deletion could, in part, lead to Wnt signaling activation during normal oligodendrocyte development.
Cytoplasmic stabilization and nuclear localization of b-catenin are important events in canonical Wnt signaling for the regulation of target gene transcription. To examine b-catenin stabilization in dCKO mice, we isolated cortical progenitors from dCKO and its control embryos and cultured them in oligodendrocyte differentiation medium to promote oligodendrocyte formation 25 . The cultures were immunostained with antibodies to the stabilized, active form of b-catenin (active b-catenin, ABC) 26 and Cre. In control Cre-positive cells, b-catenin immunostaining revealed a weak and diffuse cytoplasmic membrane pattern with a minimal amount of cytoplasmic accumulation. No nuclear accumulation of b-catenin was present in Cre-positive cells ( Fig. 3f-h) . In contrast, in the dCKO mutants, expression of the stable form of b-catenin in the Cre-positive cells appeared to accumulate in the cytoplasm, and we observed nuclear localization of b-catenin ( Fig. 3i-k) , which was confirmed by confocal analysis at the z axis level ( Fig. 3l-p) . Accumulation of the stable form of b-catenin in dCKO-derived cells was further confirmed by western blot, which showed an approximate 3.2-fold increase over the control, as determined by densitometry ( Fig. 3q ). Furthermore, phosphorylation of b-catenin in cultures derived from dCKO embryos was reduced by approximately 4.5-fold ( Fig. 3q) . The decrease of phosphorylationdependent degradation of b-catenin could result in a stabilized form of b-catenin, which could then enter the nucleus as a transcription coactivator for gene transcription 26 . Compared with control, Crepositive cells from dCKO mutants failed to mature into MBP-positive oligodendrocytes even in culture medium containing factors that promote oligodendrocyte maturation, such as thyroid hormone T3 and ciliary neurotrophic factor 27,28 (Fig. 3) . These cells were maintained as Pdgfra-positive OPCs. These observations suggest that the deletion of Hdac1/2 results in stabilization and nuclear localization of b-catenin, leading to Wnt signaling activation and oligodendrocyte differentiation failure.
Wnt signaling inhibits oligodendrocyte differentiation
To determine whether the activation of canonical Wnt signaling alone is sufficient to inhibit oligodendrocyte differentiation, we crossed the b-catenin gain-of-function allele Ctnnb1 lox(ex3) mouse line 29 with the Olig1-cre line, which excised exon 3 of the Ctnnb1 allele, producing a shortened, stable form of b-catenin that lacks its N-terminal phosphorylation and ubiquitination sites 29 , resulting in constitutive Wnt signaling activation in oligodendrocyte lineage cells.
In the spinal cord of Ctnnb1 lox(ex3) ; Olig1-cre embryos at E12.5, expression of an OPC marker Olig2 in the ventral ventricular zone was comparable to that of the control (Fig. 4a) . At E13.5, expression of Olig1 and Olig2 decreased and was maintained in a domain of the ventral ventricular zone (Fig. 4b,c) . Notably, Pdgfra expression was essentially undetectable (Fig. 4d) . Thus, Olig2-positive neuroepithelial cells in the mutant were unable to migrate and differentiate into OPCs and oligodendrocytes, and they were maintained as progenitor cells in the ventral ventricular zone. We did not detect any alteration of motor neuron and astrocyte development or an increase of cell death, as assayed with an active form of caspase 3 and TUNEL in mutants at different stages (data not shown). Thus, activation of b-catenin mediated by Olig1-cre inhibits the differentiation of Olig2positive neuroepithelial cells into oligodendrocyte lineage cells in the developing spinal cord.
Failure of oligodendrocyte formation persisted throughout the postnatal stage in Ctnnb1 lox(ex3) ; Olig1-cre mutants. In the hindbrain at P4, expression of Olig2, Pdgfra and oligodendrocyte markers Plp and Mbp were not detected in mutant mice ( Supplementary  Fig. 4 online) . Even at P14, OPCs and mature oligodendrocytes were not detected in the forebrain or cerebellum ( Fig. 4e-h) . Thus, our data indicate that constitutive activation of b-catenin in Olig1-expressing cells inhibits OPC specification, paralleling our observations in oligodendrocyte formation in mice lacking both Hdac1 and Hdac2.
Oligodendrocyte differentiation defects were also observed in the spinal cord of a mouse line with a b-catenin gain-of-function mutation that was cre excision in oligodendrocytes (Cnp-cre) 30 . Because Cre expression directed by the Cnp promoter began at or after OPCs formed, Pdgfra-positive OPCs in this mutant were largely spared ( Supplementary  Fig. 5 online) .
Conversely, we generated compound mice with Olig1-cre-mediated b-catenin loss-offunction alleles (Ctnnb1 loxP/loxP ; Olig1-cre). In the developing spinal cord of these mice at E12.75, we observed a prescheduled increase and dispersal of the oligodendrocyte progenitor markers Olig2, a paralog of Olig1, and Pdgfra, in contrast with their restricted expression in a domain of the ventral ventricular zone in controls ( Fig. 4i,j) . Our observations indicate that Wnt/b-catenin signaling participates in and negatively regulates oligodendrocyte development.
To further confirm whether the stabilized form of b-catenin represses Olig2 expression in vitro, we transfected HCN cells with a constitutively active form of b-catenin (DN89b-catenin), which lacks the N-terminal 89 amino acid phosphorylation motif, preventing degradation by the destruction complex while preserving transcriptional activity 31 . Control vector-transfected HCN cells differentiated into RIP-positive oligodendrocytes with multiple elaborated cellular processes 4 d after transfection in the presence of differentiation promoting factor IGF-1 (ref. 22) ( Supplementary  Fig. 6 online) , whereas DN89b-catenin-expressing cells were confined to a progenitor cell morphology lacking RIP-positive elaborated processes ( Supplementary Fig. 6 ). Olig2 expression was observed in all of the control vector-transfected HCN cells in the presence of IGF-1 ( Supplementary Fig. 6 ), but its expression was reduced or absent in a significant percentage of DN89b-cateninexpressing cells (P o 0.01; Supplementary Fig. 6 ). This finding is consistent with the in vivo observation that the active form of b-catenin negatively regulated Olig2 expression and therefore oligodendrocyte differentiation.
TCF7L2 is an oligodendrocyte-specific b-catenin effector b-catenin, which does not bind to DNA, activates canonical Wnt signaling by forming a bipartite transcriptional activator with a member of the DNA-binding TCF/LEF transcription factor family 9 .
To determine which TCF transcription factor(s) may potentially regulate oligodendrocyte differentiation, we examined the mRNA expression of all of the TCF/LEF factor family (LEF-1, TCF7, TCF7L1 and TCF7L2) in the developing spinal cord by in situ hybridization. In contrast with the low or nonspecific expression of Lef1, Tcf7 and Tcf7l1, the expression pattern of Tcf7l2 was reminiscent of that of the oligodendrocyte markers Zfp488, Plp and Mbp in the developing spinal cord (Fig. 5a-f ) 32 . Tcf7l2 expression appeared mainly in the ventral spinal cord and increased primarily in the white matter at perinatal stages, whereas it was reduced in the adult spinal cord (Fig. 5f) .
Using immunocytochemistry, we found that TCF7L2 colocalized with the oligodendrocyte lineage markers Olig2, Olig1, CC1 and Pdgfra in the spinal cord at P7 ( Fig. 5g-i) . The expression of TCF7L2 was weaker in Pdgfra-positive cells than in CC1-positive differentiated oligodendrocytes (Fig. 5i) . TCF7L2 was not observed in GFAP-positive astrocytes or in NeuN-positive neurons (Fig. 5j,k) . Examination of mice lacking Olig2 showed that Tcf7l2 was undetectable in the mutant (Fig. 5l,m) . Similarly, Tcf7l2 expression was detected in the cerebral white matter of the wild-type forebrain at P13 but was absent in Olig1 -/mice ( Fig. 5n-q) . This result is consistent with our previously published transcriptome profile analysis of Olig1 -/mice 16 , which showed that Tcf7l2 was downregulated in Olig1 mutants (unpublished observation, F.Y. and Q.R.L.). Of note, Tcf7l2 expression in neuronal populations of the thalamus region in the brain was not affected in Olig1 -/mice (Fig. 5n,o) . Thus, our data suggest that Tcf7l2 is expressed in oligodendrocyte lineage cells.
TCF7L2 is critical for oligodendrocyte differentiation
To examine the role of Tcf7l2 in oligodendrocyte differentiation, we first carried out a gain-of-function study in ovo. A Tcf7l2 expression vector was electroporated into the neural tube of E2.5 chick embryos and harvested at E5.5, when the differentiation of endogenous oligodendrocytes had not yet occurred 33 . Expression of transgenes in the electroporated side was confirmed by in situ hybridization ( Fig. 6 and data not shown). Misexpression of Tcf7l2 alone did not induce ectopic oligodendrocyte differentiation (Fig. 6b ). This implies that TCF7L2 alone cannot activate transcription of oligodendroglial genes and may require additional cofactors 11 . In contrast, misexpression of Tcf7l2-enR, which encodes a dominant-repressive form of TCF7L2 that has an engrailed repressor domain (enR) fused to its C terminus and lacks the b-catenin binding domain 34 , was able to promote ectopic expression of the differentiated oligodendrocyte marker Sox10 and OPC marker Pdgfra (Fig. 6c-e ). Ectopic expression of these early oligodendrocyte markers was mainly detected near the ventricular zone of the neural tube ( Fig. 6c-e ), although no mature oligodendrocytes were evident, as determined by the lack of Mbp expression ( Fig. 6f) .
In contrast, ectopic expression of another TCF family member, Lef1, and its dominantrepressive form, Lef1-enR, did not alter or promote ectopic expression of Sox10 and Pdgfra (Fig. 6h and data not shown) . These data suggest that a unique TCF7L2-mediated repressor interaction promotes oligodendroglial gene expression and de novo oligodendrocyte precursor formation. However, it is possible that other TCF factors could mediate the progression from neuroepithelial precursors to committed OPCs and that this process can be mimicked by TCF7L2-enR.
To determine whether the oligodendrocytespecific Wnt signaling effector TCF7L2 is required for oligodendrocyte development, we analyzed the expression of the markers for mature oligodendrocytes and their precursors in the spinal cords of Tcf7l2 -/embryos, which die at birth 35 . At E17.5 in Tcf7l2 -/embryos, expression of the OPC marker Pdgfra was detected throughout the spinal cord and was comparable to that of wild-type littermates (Fig. 6k,p) . In contrast, expression of the myelin genes Plp and Mbp was undetectable in Tcf7l2 -/embryos compared with the robust expression that we detected in the lateral white matter of wild-type spinal cords ( Fig. 6l,m,q,r) . In addition, expression of Gfap was not altered in the absence of Tcf7l2 (Fig. 6s) . These data suggest that the Wnt/b-catenin effector Tcf7l2 is required for oligodendrocyte differentiation or maturation but not for the formation of oligodendrocyte precursors.
HDAC1/2 suppress Wnt/b-catenin signaling activation
To examine the change in the expression of myelin genes and differentiation inhibitors in response to Wnt signaling, we treated HCN cells with the Wnt signaling ligand Wnt3a in the presence of IGF-1 and analyzed gene expression by quantitative real-time PCR (qRT-PCR) analysis. Expression of both of the oligodendrocyte inhibitors Id2 and Id4 (ref. 36, 37) was upregulated after Wnt3A treatment. We did not observe an increase of Hes1 and Hes5, Notch signaling effectors for oligodendrocyte differentiation 38 (Fig. 7a) . As expected, expression of myelin genes such as Mbp and Cnp was significantly reduced (P o 0.01, Fig. 7a ). Similar responses to Wnt3a treatment were obtained with primary OPCs isolated from rat neonates (Fig. 7a) , which is consistent with previous results indicating that Wnt3a treatment inhibits OPC differentiation 13 .
Id2 is a direct target gene of b-catenin-TCF transactivation 39, 40 and negatively regulates oligodendrocyte differentiation 36 . Mutation of the TCF7L2 binding motif in the Id2 promoter abolishes the promoter activity activated by b-catenin in colon carcinoma cells 40 . To determine the relationship of b-catenin and HDAC1/2 in regulating the expression of Wnt target genes, we examined Id2 promoter activity in the presence of b-catenin and/or HDAC1/2. As a result of the poor transfection efficiency of primary OPCs, we chose to use HCN for biochemical assays. The HCN cells have been established as precursor cells for studying oligodendrocyte differentiation 22 . Overexpression of DN89bcatenin significantly transactivated the Id2 promoter-luciferase reporter (P o 0.01; Fig. 7b ). Activation of the Id2 promoter by DN89b-catenin was suppressed by cotransfection of either HDAC1 or HDAC2, or of both HDAC1 and HDAC2 (Fig. 7b) . Similarly, activation of an Id4 promoter reporter 41 by active b-catenin was repressed by HDAC1 or HDAC2 or both (Fig. 7c) .
We monitored the effect of HDACs and b-catenin signaling on Mbp expression by coexpressing an Mbp promoter-driven luciferase reporter 42 with DN89b-catenin, HDAC1 and HDAC2. When co-transfected with the Mbp reporter, HDAC1, HDAC2 or both together increased the activity of the Mbp promoter by approximately twofold over control (Fig. 7d) , whereas DN89b-catenin reduced the promoter's activity (Fig. 7d) . In contrast, when HDAC1 or HDAC2 or both were cotransfected with the active form of b-catenin, there was a statistically significant increase in Mbp promoter-driven reporter activity, even in the presence of an active form of b-catenin (P o 0.01; Fig. 7d ). These data suggest that the inhibitory effect of b-catenin/TCF signaling on the Mbp promoter can be reversed by overexpression of HDAC1 or HDAC2 or both.
Competing interaction of b-catenin and HDACs with TCF7L2
To investigate the interaction between TCF7L2, b-catenin and HDAC1 or HDAC2, we co-transfected cDNA constructs encoding TCF7L2 and DN89b-catenin, as well as HDAC1 or HDAC2, and performed coimmunoprecipitation on cell lysates 48 h after transfection. Consistent with b-catenin binding to a member in the LEF/TCF transcription factor family 11 , we detected an association of DN89b-catenin and TCF7L2 (Fig. 7e) . Similarly, immunoprecipitation of TCF7L2 was able to pull down b-catenin in a complex (Fig. 7f) . In contrast, no b-catenin was detected in association with HDAC1 or HDAC2 in the co-immunoprecipitated complex (Fig. 7g) .
Inhibition of b-catenin-driven transactivation by HDAC1/2 could result from either displacement of TCF7L2 binding to b-catenin by HDACs or the formation of a ternary complex (HDAC-TCF7L2b-catenin) that has no transactivation potential. To distinguish between these possibilities, we co-transfected TCF7L2 and expression vectors for DN89b-catenin, HDAC1 or HDAC2. After transfection, the TCF7L2 complex was immunoprecipitated with antibody to TCF7L2. In the absence of DN89b-catenin, both HDAC1 and HDAC2 were detected in the same complex containing TCF7L2 by western blot analysis (Fig. 7h) . In the presence of a low level of DN89b-catenin, a small amount of Flag-tagged HDAC1, but not HDAC2, was detected in the co-immunoprecipitated complex (Fig. 7h) . In the presence of a high level of DN89b-catenin, neither HDAC1 nor HDAC2 was associated with the TCF7L2 complex (Fig. 7h) . These data are consistent with a model ( Supplementary Fig. 7  online) in which b-catenin competes with HDAC1 and/or HDAC2 to interact with TCF7L2 to inhibit oligodendrocyte differentiation. Conversely, dissociation and attenuation of TCF7L2-bound b-catenin by HDAC1/2 result in a template that is poised for oligodendrocyte differentiation.
DISCUSSION
Oligodendrogenesis occurs in a spatially and temporally specific manner and is regulated by the interplay of multiple integrated genetic and epigenetic factors. We found that the chromatin remodeling enzymes HDAC1 and HDAC2 regulate oligodendrocyte specification and differentiation, at least in part, by inhibiting b-catenin/TCF7L2 complex formation.
Redundant roles of HDAC1/2 in oligodendrocyte development
HDACs have been implicated in oligodendrocyte development on the basis of the ability of HDAC inhibitors to block oligodendrocyte differentiation 3, 4 . However, it is important to determine whether the effects of HDAC inhibitors reflect the combined inhibition of multiple HDACs or specific functions of individual HDACs. A recent study using morpholino-antisense knockdown in zebrafish suggested that hdac1 is essential for oligodendrocyte formation 5 . In addition, siRNAmediated knockdown of either Hdac1 or Hdac2 is sufficient to block oligodendrocyte differentiation in vitro 43 . We found that mutant mice with oligodendrocyte lineage-specific ablation of Hdac1 or Hdac2 alone did not develop discernable defects in oligodendrocyte development, but simultaneous deletion of both Hdac1 and Hdac2 resulted in a complete loss of oligodendrocytes. The discrepancies between our results and those of previous studies might be a result of species difference (for example, mouse versus zebrafish) and potential crosstargeting of Hdac1 or Hdac2 siRNA on both Hdac genes resulting from high sequence homology between Hdac1 and Hdac2.
The ablation of Hdac1/2 directed by Olig1-cre does not affect the formation of other neural cell types, including motor neurons and astrocytes, in the developing CNS. This observation most likely reflects a specific requirement of Hdac1/2 in oligodendrocyte formation rather than a general requirement for neural cell-type specification. The presence of OPCs in cortical progenitor culture from dCKO embryos is intriguing, as no committed OPCs were detected in vivo, although Hdac1/2 ablation inhibits terminal differentiation of OPCs in vitro. Nonetheless, such altered differentiation potential of progenitor populations in culture has been observed in other cell types 44 . In this vein, it is possible that extrinsic components in the culture medium or the absence of inhibitory signals that are normally present in the CNS enable OPC formation in vitro in the absence of Hdac1/2. Alternatively, OPCs were specified in cortical progenitor culture before Olig1-cre-mediated Hdac1/2 deletion.
b-catenin/TCF7L2 regulates oligodendrocyte differentiation
We found that HDAC1/2 ablation led to Wnt signaling activation by stabilization and nuclear translocation of b-catenin. Constitutive activation of Wnt/b-catenin signaling inhibited oligodendrocyte differentiation, at least partially, by activating the expression of the differentiation inhibitors Id2/4 while repressing Olig2 and Mbp gene expression. Notably, neural progenitor cells that were either treated with Wnt3a or had Hdac1/2 deleted did not show an increase of Notch signaling effectors, suggesting that the effect of Wnt signaling activation on oligodendrocyte differentiation is independent of the Notch pathway. Considering its strong inhibitory effects, the activation of canonical Wnt signaling may serve as a key inhibitory factor for blocking oligodendrocyte differentiation in the developing CNS and, perhaps, oligodendrocyte remyelination after demyelinating injury.
Through expression pattern analysis of TCF/LEF family members and transcriptome profiling analysis of wild-type and Olig1 À/À mice, we identified a b-catenin co-effector, TCF7L2, as being an oligodendrocyte lineage-specific transcription factor. Overexpression of a dominant-repressive form of TCF7L2, but not LEF1, was observed to promote ectopic and premature OPC specification in the developing chick neural tube. This observation suggests that a unique association of TCF7L2 with transcriptional co-repressor(s) would promote oligodendrocyte specification from neural progenitor cells.
The defect in oligodendrocyte maturation in Tcf7l2 -/mutants suggests that TCF7L2 is critical for oligodendrocyte differentiation. Thus, TCF7L2 serves as an important DNA-binding component in the transcriptional complex that regulates oligodendrocyte development. The absence of apparent defects in oligodendrocyte precursor formation in Tcf7l2 -/mutants may reflect the fact that additional TCF factors may utilize HDAC1/2 as a co-repressor to promote oligodendrocyte precursor specification from neural progenitor cells.
Convergence of b-catenin and HDAC1/2 on TCF7L2 interaction
How do HDAC1 and HDAC2 suppress the Wnt signaling pathway? Because HDAC proteins are recruited by transcriptional repressors such as Groucho/TLE-related factors 11, 45 , it is possible that HDAC1/2 co-repressors switch off transcription of Wnt signaling-activated genes. Our data suggest that HDAC1/2 antagonize Wnt signaling to suppress the expression of differentiation inhibitors (IDs) and permit or promote Mbp gene expression. Alternatively, HDACs may affect other unidentified pathways besides competing with the inhibitory b-catenin pathway for oligodendrocyte differentiation.
The fact that a dominant-repressive form of TCF7L2 promotes ectopic precocious oligodendrocyte formation suggests that oligodendrocyte differentiation is mediated by a TCF7L2/co-repressor complex. Our observations are consistent with the idea that HDAC1/2 or theirassociated co-repressors may directly compete with b-catenin to interact with TCF7L2. The competition of HDAC1/2 proteins with b-catenin converts TCF7L2 from being a transcriptional repressor to being an activator for oligodendrocyte differentiation, suggesting that TCF7L2 functions as a convergent regulator for oligodendrocyte differentiation. Such a direct competition model suggests that a balance or ratio between HDAC1/2 and b-catenin on TCF7L2 transcriptional activity may control the timing of oligodendrocyte differentiation and maturation ( Supplementary Fig. 7) .
Implications for human disease
HDACs have been implicated in a wide range of cellular processes and disease states on the basis of the ability of HDAC inhibitors to improve various disease pathologies 46, 47 . However, inhibition of HDACs, particularly HDAC1/2, could cause white matter injury and the potential cancer risk of Wnt signaling activation. Our results and those of others 43 emphasize the need to develop specific HDAC inhibitors to avoid potential side effects in myelin regeneration. In addition, inhibition of canonical b-catenin-mediated Wnt signaling in conjunction with augment of HDAC1/2 activity may offer a therapeutic approach to promoting oligodendrocyte regeneration and myelin repair.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
Tissue collection and RNA in situ hybridization. Brains and spinal cords from wild types and mutants at various embryonic and postnatal stages were harvested from ketamine/xylazine anesthetized mice, fixed in 4% paraformaldehyde (wt/vol) at 4 1C overnight, infused with 20% sucrose (wt/vol) in phosphate-buffered saline overnight, embedded in optimal cutting temperature medium and cryosectioned at 16 mm. Digoxigenin-labeled riboprobes were used to perform RNA in situ hybridization as described previously 6 . We used probes to murine Olig1, Olig2, Pdgfra, Plp1, Mbp, Tcf7l2, Lef1 and Gfap and to chick Pdgfra, Sox10 and Mbp. Detailed protocols are available on request. Recombinant mouse Wnt-3a was purchased from R&D Systems. For all rodent embryonic litters analyzed, noon of the day of vaginal plug detection was considered to be E0.5.
qRT-PCR. qRT-PCR was performed using the ABI Prism 7700 Sequence Detector System (Perkin-Elmer Applied Biosystems). qRT-PCR was carried out as previously described 16 . The primers used for expression analyses are available on request.
Hippocampus-derived adult neural progenitor cells and oligodendroglial cell cultures. The hippocampus-derived HCN cells were originally isolated from adult (8-10 weeks old) female Fisher 344 rats and have been characterized previously 22 . They give rise to homogeneous populations of oligodendrocytes on IGF-1 stimulation 22 . HCN cells were cultured in N2-FGF media (DMEM:F12 with N2 supplement (Invitrogen) and basic fibroblast growth factor, 20 ng ml -1 FGF-2). In the presence of 100 ng ml -1 of IGF-1, the HCN cells expressed Olig2 ( Supplementary Fig. 6 ) and can be induced into differentiated oligodendrocytes 22 . Using the HCN cells for our reporter assay and biochemical studies has been established in previous studies, including for the Mbp promoter-driven reporter assay 22, 48 .
Primary OPCs were isolated from rat pups at P2 as previously described 25 . For mouse primary oligodendroglial-enriched cell cultures, cortical precursors were isolated from E15.5 as described previously 25 . The mouse cortical neural stem/progenitors were derived from controls, and HDAC mutant embryos were grown in the N2-bFGF growth medium for 5 d to enrich for Olig2-positive OPCs 49 , then passaged by trypsinization and cultured in oligodendrocyte growth medium (N2 supplemented with bFGF and PDGF-AA) and oligodendrocyte differentiation medium (N2 supplemented with T3 and ciliary neurotrophic factor) to promote oligodendrocyte differentiation as previously described 25 . Most of the neurons did not survive after precursor cell passaging when cultured in the oligodendrocyte growth medium (data not shown). Thus, oligodendrocyte precursors were enriched in serum-free oligodendrocyte growth medium 25 .
Transient transfection, luciferase assay and immunohistochemistry. HCN progenitor cells were seeded and grown in DMEM with N2 supplemented with IGF-1 (100 ng ml -1 ) before transfection with Amaxa according to the manufacturer's protocol and assayed 72 h post-transfection for immunocytochemistry and qRT-PCR analysis. The immunohistochemical staining procedure was performed as described previously 16 . We used antibodies to Olig1 and Olig2 (gift of C. Stiles, Harvard Medical School), PDGFRa (BD Bioscience), CC1 (Oncogene Research), NG2, PECAM1, NeuN, and glutamine synthetase (Chemicon), BrdU, GFAP (Sigma), Ki67 (Thermo Scientific), and ABC, phosphorylated b-catenin, TCF7L2 and caspase-3 (Millipore). Monoclonal antibodies to Hb9 (MNR2) and RIP were obtained from the Developmental Studies Hybridoma Bank at the University of Iowa under the auspices of the National Institute of Child Health and Human Development. X-gal staining for b-galactosidase activity was carried out as previously described 6 . Luciferase assays were performed by using a Promega luciferase assay kit. In addition, the pRSV-renilla luciferase plasmid was included to control for variable transfection efficiencies between different experiments.
Co-immunoprecipitation and immunoblotting. HCN cells or HEK293 cells were transiently transfected with 10 mg of Tcf7l2, pDN89b-catenin and pFlag-HDAC1 or 2 in pCIG vector 50 . Whole-cell lysates were prepared 48 h after transfection by using 1Â Passive lysis buffer (Promega) supplemented with a protease inhibitor cocktail (1:200, Sigma). For immunoprecipitation, 600 mg of cell lysate proteins were incubated with 10 mg of antibody to TCF7L2 or b-catenin as described previously 32 . After western blotting, proteins carrying the Flag epitope tag were detected with monoclonal mouse antibody to Flag (Clontech Laboratories) by using chemiluminescence with the ECL kit (Pierce) according to the instruction of the manufacturer.
Chick embryo in ovo electroporation. Chicken eggs were incubated at B38 1C. Approximately 1 ml (1.5 mg ml -1 ) of expression vector (pCIG) carrying gfp, DN89Ctnnb1, Tcf7l2, Lef1, Tcf7l2-enR or Lef1-enR was injected into a chicken embryo neural tube at stage HH 13-15 (E2.5) with the aid of Picospritzer III (Parker Hannifin). The subsequent electroporation was performed by using a square-wave electroporator (CUY21, BEX Co. LTP) with five pulses of electrical shock (25 V, 50 ms for each pulse). Embryos were harvested 3 d after electroporation. At this stage (E5.5), none of oligodendrocyte markers are normally expressed in the neural tube. The green fluorescent segment of the neural tube was dissected, fixed for 1 h in 4% paraformaldehyde-phosphate-buffered saline on ice and embedded in OCT for sectioning on a cryostat for in situ hybridization or immunohistochemistry. At least five embryos with expression of each transgene were analyzed and characterized.
Statistic analysis. Quantifications were performed from at least three experimental groups. Data are presented as mean ± s.d. P values were determined by Student's two-tailed t test between control and experimental groups. For multiple comparisons, which were done using one-way ANOVA with post-test, we used the Newman-Keuls multiple comparison test. Animal use and studies were approved by the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center at Dallas. 48. Kuwabara, T., Hsieh, J., Nakashima, K., Taira 
